Literature DB >> 3156016

Abnormalities in the expression of the leucocyte-common antigen in chronic lymphocytic leukaemia.

S K Smith, V A Brown, A E Dewar, G Stockdill, B Cohen, A H Maddy.   

Abstract

The surface glycoproteins of lymphocytes isolated from patients suffering from B cell chronic lymphocytic leukaemia (B-CLL) have been studied by radioactive labelling with impermeable probes and with MoAb. Several features not found in normal B cells have been observed. The abnormalities found in the expression of polypeptides of the leucocyte common (L-C) antigen, identified by appropriate MoAb, have been examined in detail. It has been shown by both biochemical analysis and MoAb binding that this group of polypeptides can, within a panel of B-CLL patients, range from a typical B cell pattern to the pattern resembling that normally found in T cells. The T lymphocyte profile is correlated with a poor prognosis (MVA C rating) and in the one patient where a change in the glycoprotein profile towards that of the T cell was observed, the change coincided with a clinical deterioration. The biological significance of the molecular diversity is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156016      PMCID: PMC1577181     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography.

Authors:  R A Laskey; A D Mills
Journal:  Eur J Biochem       Date:  1975-08-15

2.  A procedure for removing red cells and dead cells from lymphoid cell suspensions.

Authors:  W F Davidson; C R Parish
Journal:  J Immunol Methods       Date:  1975-06       Impact factor: 2.303

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Surface glycoproteins in chronic lymphocytic leukaemias.

Authors:  S K Smith; A H Maddy
Journal:  Biochem Soc Trans       Date:  1984-06       Impact factor: 5.407

6.  Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter.

Authors:  D R Parks; V M Bryan; V T Oi; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

7.  Receptors for Helix pomatia A haemagglutinin (HP) on a subpopulation of human B cells.

Authors:  U Hellström; P Perlmann; E S Robertsson; S Hammarström
Journal:  Scand J Immunol       Date:  1978-03       Impact factor: 3.487

8.  Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells.

Authors:  T H Tötterman; K Nilsson; C Sundström
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

9.  Monoclonal antibody to a human leukocyte-specific membrane glycoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat.

Authors:  R Dalchau; J Kirkley; J W Fabre
Journal:  Eur J Immunol       Date:  1980-10       Impact factor: 5.532

10.  Identification with a monoclonal antibody of a predominantly B lymphocyte-specific determinant of the human leukocyte common antigen. Evidence for structural and possible functional diversity of the human leukocyte common molecule.

Authors:  R Dalchau; J W Fabre
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

View more
  2 in total

1.  The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukaemia.

Authors:  A H Maddy; A Sanderson; M J Mackie; S K Smith
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

2.  Surface glycoproteins as markers of the cellular status of B chronic lymphocytic leukaemia lymphocytes.

Authors:  V A Brown; S K Smith; A E Dewar; G Stockdill; A H Maddy
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.